MedTrace Logo

Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

NCT06224777 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-01-25

No results posted yet for this study

Summary

The goal of this comparative, interventional randomized controlled trial is to use albumin during resuscitation in pediatric burn patients on day 2, as it can reduce extravasation of fluids and decrease the overall fluid requirements, along with mortality and maintain circulation.

Participants will be divided into 2 groups. Albumin will be administered additionally in group A, while only crystalloids will be used for resuscitation in group B.

Conditions

  • Burns

Interventions

BIOLOGICAL

5% Albumin (human) Solution

Albumin is a biological product derived from human blood donors.

DRUG

Paeds solution

Paeds solution contains dextrose 4.3%, and Sodium Chloride 0.18%

Sponsors & Collaborators

  • King Edward Medical University

    lead OTHER

Principal Investigators

  • Fatima Naumeri, MBBS,FCPS · King Edward Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-18
Completion
2023-05-17

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06224777 on ClinicalTrials.gov